InvestorsHub Logo
icon url

Smokey21

03/04/15 7:34 AM

#30125 RE: Rkmatters #30123

Excellent post RK. You depicted my strategy exactly. It's a game of calculating odds and taking risks. For those not comfortable with risk, there are always safer plays with less potential returns.
icon url

Diamondjim61

03/04/15 7:39 AM

#30127 RE: Rkmatters #30123

I could read that one without a translator.

... ok, I could read most of it.

I especially liked this portion, which sums it all up (for me at least)...

In this study, we report the results of a phase I clinical trial in which glioblastoma patients were treated with a personalized immunotherapy approach, comprised of autologous tumor lysate-pulsed dendritic cell vaccination. In addition, we utilized gene expression profiling to identify a group of patients with a particular gene expression signature (mesenchymal glioblastoma) that had longer survival following DC vaccination, compared to contemporary/historical control patients of the same gene expression subgroup, who did not receive vaccination.

icon url

Homework.Investwell

03/04/15 8:54 AM

#30132 RE: Rkmatters #30123

You're correct Rkmatters. I think some of us need to remember what we're waiting for.....clinical results. All we have are earlier updates so it does not hurt to go back. :)

http://www.nwbio.com/dcvax-direct-trial-update-indicates-further-positive-responses-3-case-studies-show-no-live-tumor-cells-in-injected-tumors/

DCVax-Direct Trial Update Indicates Further Positive Responses; 3 Case Studies Show No Live Tumor Cells In Injected Tumors

All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease

These are game changing results. We now need to know if they've improved (my prediction/speculation) on these numbers.
"STAY TUNED" LOL!!!!!